Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sample Preparation Kits to Be Automated

By LabMedica International staff writers
Posted on 28 May 2013
Liquid-handling robots are important tools for labs seeking to increase throughput and consistency. More...
Robots make processes more efficient, reduce hands-on time, and minimize human errors by automating labor-intensive pipetting steps.

Illumina, Inc. (San Diego, California, USA) is collaborating with providers of liquid handling robotic platforms to develop automation methods for its TruSeq and Nextera sample preparation kits. The initial partners are Beckman Coulter Life Sciences, Eppendorf, Hamilton Robotics, PerkinElmer, and Tecan.

Under the agreements, sample preparation kits sold by Illumina will be automated by the partners, who will develop, distribute, and install the methods on customers' robots, as well as provide technical support. Illumina will assist during development, testing, and promotion of the methods. Methods for TruSeq RNA sample preparation kits will be available by end of second quarter 2013, with automation methods for additional TruSeq and Nextera kits to follow.

Automating sequencing library preparation minimizes errors, reduces hands-on time, and enables higher throughput. TruSeq and Nextera kits are designed with master-mixed reagents and simplified sample prep protocols to facilitate automation.

"We are excited to work with the top automation providers to deliver solutions that can be readily implemented in the lab, thus saving time for our customers and making automation much more accessible," said Christian Henry, senior vice president and general manager of Illumina's Genomic Solutions business. "TruSeq and Nextera sample preparation kits are designed with master-mixed reagents and simplified protocols to facilitate automation. In the long term, the new methods will allow more samples to be run simultaneously and with fewer errors, while freeing up resources so that customers can focus on their scientific goals."

Illumina's library prep kits can be automated on most general-purpose liquid-handling robots. Various vendors have developed methods for Illumina's kits; by using these, customers save the time and effort required to develop their own methods.

Illumina also helps make sequencing sample prep automation more accessible by partnering with leading automation vendors in liquid handling, fragmentation, and size selection. The resulting solutions and methods facilitate kit automation, leading to an unparalleled next-generation sequencing workflow and the easiest, most efficient way to go from samples to biologically relevant data.

Related Links:
Illumina



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.